Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0021
-0.0001 (-4.55%)
Oct 17, 2025, 3:59 PM EDT
Halberd Market Cap
Halberd has a market cap or net worth of $1.49 million as of October 17, 2025. Its market cap has decreased by -55.51% in one year.
Market Cap
1.49M
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 1.49M, a decrease of -43.00%. That is a compound annual growth rate of -3.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.49M | -41.60% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | 8.34M | 1,228.60% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 749.94M |
| Elite Pharmaceuticals | 652.54M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| CytoDyn | 365.33M |
| Northwest Biotherapeutics | 360.44M |
| Silence Therapeutics | 301.35M |
| American Oncology Network | 291.58M |